Steven J. Mento
2022
In 2022, Steven J. Mento earned a total compensation of $560.3K as President & Chief Executive Officer at Conatus Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250 |
|---|---|
| Option Awards | $28,156 |
| Salary | $531,917 |
| Total | $560,322 |
Mento received $531.9K in salary, accounting for 95% of the total pay in 2022.
Mento also received $250 in non-equity incentive plan and $28.2K in option awards.
Rankings
In 2022, Steven J. Mento's compensation ranked 4,176th out of 5,760 executives tracked by ExecPay. In other words, Mento earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,176 out of 5,760 | 28th |
Division Manufacturing | 2,360 out of 3,136 | 25th |
Major group Chemicals And Allied Products | 1,150 out of 1,422 | 19th |
Industry group Drugs | 1,080 out of 1,323 | 18th |
Industry Pharmaceutical Preparations | 790 out of 969 | 19th |
Source: SEC filing on May 1, 2023.
Mento's colleagues
We found two more compensation records of executives who worked with Steven J. Mento at Conatus Pharmaceuticals in 2022.